"10.1371_journal.pone.0063881","plos one","2013-05-08T00:00:00Z","Paola Bargagna-Mohan; Sunil P Deokule; Kyle Thompson; John Wizeman; Cidambi Srinivasan; Sunil Vooturi; Uday B Kompella; Royce Mohan","Neuroscience, University of Connecticut Health Center, Farmington, Connecticut, United States of America; Ophthalmology and Visual Science, University of Kentucky, Lexington, Kentucky, United States of America; Statistics, University of Kentucky, Lexington, Kentucky, United States of America; Pharmaceutical Sciences, University of Colorado Denver, Aurora, Colorado, United States of America","Conceived and designed the experiments: PBM SD RM. Performed the experiments: PBM SD KT JW SV. Analyzed the data: PMB SD KT CS SV JW UBK RM. Contributed reagents/materials/analysis tools: SD CS UBK RM. Wrote the paper: PBM SD KT CS SV UBK RM.","Paola Bargagna-Mohan and Royce Mohan report the following patents: United States patent (US patent # 8283323; Title: WITHANOLIDE COMPOUNDS AS INHIBITORS OF FIBROSIS AND IDENTIFICATION OF MOLECULAR TARGETS FOR ANTI-FIBROTIC DRUG DEVELOPMENT). A US patent application pending that directly implicates vimentin-targeting activity of WFA is still under consideration at the USPTO (US Patent application# 20080207574; Title: WITHANOLIDES, PROBES AND BINDING TARGETS AND METHODS OF USE THEREOF). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","05","Paola Bargagna-Mohan","PBM",8,TRUE,3,5,8,7,TRUE,FALSE,FALSE,0,NA,FALSE
